Goodwin Charles D. II
SEC CIK 1726988 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| APYX | Apyx Medical Corp | CEO, Dir | 90.0K | $148.6K | — | 2 | 2022-08-29 | 2023-11-14 |
Most active insiders at APYX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Roman Shawn David | COO | — | — |
| 2 | Vizirgianakis Stavros G. | Dir | — | — |
| 3 | Waldman Lawrence | Dir | — | — |
| 4 | CITRONOWICZ MOSHE | SVP | — | — |
Goodwin Charles D. II made no open-market trades at APYX in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-15 | 2023-11-14 | APYX | Apyx Medical Corp | Goodwin Charles D. II | CEO, Dir | P - Purchase | $1.57 | +50.0K | 90.0K | +125% | +$78.5K | |
| M | 2022-08-31 | 2022-08-29 | APYX | Apyx Medical Corp | Goodwin Charles D. II | CEO, Dir | P - Purchase | $5.96 | +11.8K | 30.2K | +64% | +$70.1K |
Purchase Sale Sale after option exercise All abbreviations